Paper35866252
Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application.
Jung M and 4 others. Adv Healthc Mater, 2022. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application. Papers, record 35866252. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35866252
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bioprinting | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Precision Medicine | |
| Printing, Three-Dimensional | |
| Biology | |
| Tissue Engineering | |
| Tissue Scaffolds | |
| Tumor Microenvironment |
Source PubMed
References131
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17535867 | Changes in calf muscle elasticity in hypogonadal males before and after testosterone substitution as monitored by magnetic resonance elastography. | Eur J Endocrinol | 2007 | https://conductscience.org/library/papers/17535867 | PubMed |
| 2 | 28331002 | Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. | Cancer Discov | 2017 | https://conductscience.org/library/papers/28331002 | PubMed |
| 3 | 19931152 | Matrix crosslinking forces tumor progression by enhancing integrin signaling. | Cell | 2009 | https://conductscience.org/library/papers/19931152 | PubMed |
| 4 | 32775607 | Hydrogel-based 3D bioprinting: A comprehensive review on cell-laden hydrogels, bioink formulations, and future perspectives. | Appl Mater Today | 2020 | https://conductscience.org/library/papers/32775607 | PubMed |
| 5 | 30413828 | The clinical role of the TME in solid cancer. | Br J Cancer | 2019 | https://conductscience.org/library/papers/30413828 | PubMed |
| 6 | 33089109 | A 3D Bioprinter Specifically Designed for the High-Throughput Production of Matrix-Embedded Multicellular Spheroids. | iScience | 2020 | https://conductscience.org/library/papers/33089109 | PubMed |
| 7 | 26696527 | A simple and high-resolution stereolithography-based 3D bioprinting system using visible light crosslinkable bioinks. | Biofabrication | 2015 | https://conductscience.org/library/papers/26696527 | PubMed |
| 8 | 29562660 | Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29562660 | PubMed |
| 9 | 19217873 | Rheology and confocal reflectance microscopy as probes of mechanical properties and structure during collagen and collagen/hyaluronan self-assembly. | Biophys J | 2009 | https://conductscience.org/library/papers/19217873 | PubMed |
| 10 | 32843638 | The updated landscape of tumor microenvironment and drug repurposing. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32843638 | PubMed |
| 11 | 22159717 | The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. | Mol Cell Proteomics | 2012 | https://conductscience.org/library/papers/22159717 | PubMed |
| 12 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 13 | 34556340 | 3D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models. | Trends Biotechnol | 2022 | https://conductscience.org/library/papers/34556340 | PubMed |
| 14 | 34927798 | In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer. | EMBO Mol Med | 2022 | https://conductscience.org/library/papers/34927798 | PubMed |
| 15 | 33672626 | Natural Biomaterials and Their Use as Bioinks for Printing Tissues. | Bioengineering (Basel) | 2021 | https://conductscience.org/library/papers/33672626 | PubMed |
| 16 | 31148598 | A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy. | Nat Biomed Eng | 2019 | https://conductscience.org/library/papers/31148598 | PubMed |
| 17 | 30459432 | Assessing the elastic properties of skeletal muscle and tendon using shearwave ultrasound elastography and MyotonPRO. | Sci Rep | 2018 | https://conductscience.org/library/papers/30459432 | PubMed |
| 18 | 27123816 | A practical guide to hydrogels for cell culture. | Nat Methods | 2016 | https://conductscience.org/library/papers/27123816 | PubMed |
| 19 | 33912551 | 3D Cancer Models: The Need for a Complex Stroma, Compartmentalization and Stiffness. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/33912551 | PubMed |
| 20 | 20162561 | Matrigel: a complex protein mixture required for optimal growth of cell culture. | Proteomics | 2010 | https://conductscience.org/library/papers/20162561 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42602561 | dECM bioinks for 3D bioprinted tumor models: Advances, challenges, and drug screening. | iScience | 2026 | https://conductscience.org/library/papers/42602561 | PubMed |
| 42536735 | Stiff matrix impairs cytotoxic T lymphocyte function at multiple levels. | Sci Adv | 2026 | https://conductscience.org/library/papers/42536735 | PubMed |
| 42328780 | Matrix Stiffness Directs Stemness Signatures in Breast Cancer. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42328780 | PubMed |
| 42256398 | Exploiting signal transduction pathways for cancer therapy: insights from natural products in preclinical models. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42256398 | PubMed |
| 42032323 | Engineering macrophages for cancer immunotherapy: emerging insights and therapeutic potential. | NPJ Biomed Innov | 2026 | https://conductscience.org/library/papers/42032323 | PubMed |
| 41828336 | The Future of Breast Cancer Treatment: From Conventional Wisdom to Nanotechnology-Enabled Precision. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828336 | PubMed |
| 41761263 | Recapitulating the tumour microenvironment: advancing personalised radiation therapy through organoid technology. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/41761263 | PubMed |
| 41491196 | Tumor-on-chip's alliance with molecular pathology against metastatic disease. | J Biomed Sci | 2026 | https://conductscience.org/library/papers/41491196 | PubMed |
| 41440181 | High-Throughput 3D Bioprinted Organoids of Skin Cancer Utilized for Diagnosis and Personalized Therapy. | Curr Oncol | 2025 | https://conductscience.org/library/papers/41440181 | PubMed |
| 41413532 | Three-dimensional bioprinting of patient-derived Gastrointestinal stromal tumor: a novel platform for precision oncology and drug response profiling. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41413532 | PubMed |
| 41158775 | From mechanisms to precision medicine: the role of organoids in studying the gut microbiota-tumor microenvironment axis. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41158775 | PubMed |
| 41085522 | A 3D Bioprinted Pancreatic Cancer Model Using Collagen-Gelatin Methacrylamide-Alginate Bioinks to Mimic the Desmoplastic Microenvironment. | Biomacromolecules | 2025 | https://conductscience.org/library/papers/41085522 | PubMed |
| 41050078 | Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug Resistance. | Oncol Res | 2025 | https://conductscience.org/library/papers/41050078 | PubMed |
| 40733293 | Applications and Recent Advances in 3D Bioprinting Sustainable Scaffolding Techniques. | Molecules | 2025 | https://conductscience.org/library/papers/40733293 | PubMed |
| 40591169 | Tumor-infiltrating nerves: unraveling the role of cancer neuroscience in tumorigenesis, disease progression, and emerging therapies. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40591169 | PubMed |
| 39697234 | Advances in the application of colorectal cancer organoids in precision medicine. | Front Oncol | 2024 | https://conductscience.org/library/papers/39697234 | PubMed |
| 39242807 | A translational framework to DELIVER nanomedicines to the clinic. | Nat Nanotechnol | 2024 | https://conductscience.org/library/papers/39242807 | PubMed |
| 39205873 | Advanced tumor organoid bioprinting strategy for oncology research. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/39205873 | PubMed |
| 39169896 | The potential of hydrogel-free tumoroids in head and neck squamous cell carcinoma. | Cancer Med | 2024 | https://conductscience.org/library/papers/39169896 | PubMed |
| 38896849 | Advancing Synthetic Hydrogels through Nature-Inspired Materials Chemistry. | Adv Mater | 2024 | https://conductscience.org/library/papers/38896849 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35866252
GET https://conductscience.org/api/papers/v1/35866252/references?page=2